Canada Pension Plan Investment Board’s Madrigal Pharmaceuticals MDGL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6M	Buy	29,080 +16,820	+137%	+$8.62M	0.01%	593
2026 Q1	$6.42M	Sell	12,260 -33,860	-73%	-$16.2M	﹤0.01%	730
2025 Q4	$26.9M	Buy	46,120 +37,120	+412%	+$19M	0.02%	458
2025 Q3	$4.13M	Buy	9,000 +3,600	+67%	+$1.34M	﹤0.01%	781
2025 Q2	$1.63M	Buy	5,400 +4,300	+391%	+$1.28M	﹤0.01%	907
2025 Q1	$364K	Sell	1,100 -12,300	-92%	-$4.04M	﹤0.01%	992
2024 Q4	$4.13M	Buy	+13,400	New	+$3.77M	﹤0.01%	740
2023 Q3	–	Sell	-6,100	Closed	-$1.41M	–	1052
2023 Q2	$1.41M	Buy	+6,100	New	+$1.65M	﹤0.01%	780

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board's MDGL Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Madrigal Pharmaceuticals (MDGL) stake by 137% in Q2 2026, buying an estimated $8.62M and bringing the position to 29,080 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #593.

Canada Pension Plan Investment Board first reported a position in MDGL in Q2 2023 and has held it in 8 quarters since. The position peaked at $26.9M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Canada Pension Plan Investment Board held 29,080 shares of Madrigal Pharmaceuticals worth $15.6M as of Q2 2026.
Canada Pension Plan Investment Board bought 16,820 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $8.62M.
Madrigal Pharmaceuticals made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #593 holding.
Canada Pension Plan Investment Board first reported a position in Madrigal Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
Canada Pension Plan Investment Board's Madrigal Pharmaceuticals position peaked at $26.9M in Q4 2025.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.